Glumetza Buyers Get Cert. In Suit Over 800% Price Jump
A California federal judge on Friday certified a proposed class of diabetes drug buyers who accuse drugmakers of violating antitrust laws by blocking a generic version of Glumetza, saying it will...To view the full article, register now.
Already a subscriber? Click here to view full article